Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Braz Oral Res ; 33: e050, 2019 Jul 01.
Article in English | MEDLINE | ID: mdl-31269114

ABSTRACT

The present study aimed to investigate the use of platelet-rich plasma (PRP) on tooth extraction sites in rats treated with bisphosphonates. Thirty Albinus Wistar male rats were administered 0.035 mg/kg zoledronic acid intravenously for 8 weeks, divided into four administrations with a 2-week interval between each application, after which their upper right central incisors were extracted to induce the development of bisphosphonate-related osteonecrosis of the jaw (BRONJ). The samples were divided into the following two groups: Group 1 (G1) underwent marginal resection of BRONJ followed by the use of PRP, while Group 2 (G2) underwent resection of BRONJ but without the use of PRP. The treatment groups were evaluated after 14, 28, and 42 days. Clinical, microtomographic, microscopic, and immunohistochemical (IHC) evaluations were performed. Microtomography results revealed no significant difference between the groups (p <0.05) in any time period. Histomorphometric analysis showed increased bone formation over time for both groups (p < 0.001). G1 demonstrated a greater amount of new bone formation than G2 at 28 and 42 days (p < 0.001), with G1 presenting greater vascularization and a slightly higher VEGF expression. For both groups, RANKL/OPG expression levels were sufficient as a parameter for indicating the rate of bone remodeling in a previously treated area of osteonecrosis groups. Taken together, our findings indicated that the use of PRP improves the resolution process of BRONJ.


Subject(s)
Bisphosphonate-Associated Osteonecrosis of the Jaw/therapy , Bone Density Conservation Agents/therapeutic use , Diphosphonates/therapeutic use , Platelet-Rich Plasma , Animals , Bisphosphonate-Associated Osteonecrosis of the Jaw/pathology , Bisphosphonate-Associated Osteonecrosis of the Jaw/physiopathology , Disease Models, Animal , Male , Osteoclasts/drug effects , Rats , Rats, Wistar , Tooth Extraction/adverse effects , Wound Healing
2.
PLoS One ; 14(6): e0214173, 2019.
Article in English | MEDLINE | ID: mdl-31199812

ABSTRACT

Treatment with cumulative dosages of zoledronic acid (ZA) in elderly patients is a risk factor for the development of medication-related osteonecrosis of the jaws (MRONJ), mainly related to surgical triggers such as tooth extraction. However, animal models for the investigation and understanding of MRONJ pathophysiology in senescent and postmenopausal stages remains to be developed and characterized. The aim of this study was to analyze MRONJ development in senescent female mice treated with cumulative dosages of ZA. For this purpose, twenty 129/Sv female mice, 64 weeks old, were treated with 0.9% saline solution as control group (n = 10), and with ZA at 250µg/Kg (n = 10), once a week, starting 4 weeks before the upper right incisor extraction and until the end of the experimental time points (7 days and 21 days). At 7 and 21 days post-surgery, specimens were harvested for microCT, histological, birefringence and immunohistochemical analysis. Clinically, an incomplete epithelialization was observed in ZA group at 7 days and a delayed bone matrix mineralization and collagen maturation at 7 and 21 days compared to the controls. Controls revealed sockets filled with mature bone at 21 days as observed by microCT and birefringence, while ZA group presented delayed bone deposition at 7 and 21 days, as well increased leukocyte infiltration and blood clot at 7 days, and increased bone sequestrum and empty osteocyte lacunae at 21 days (p<0.05). Also, ZA group presented decreased quantity of TGFb+ and Runx-2+ cells at 7 days, and decreased quantity of TRAP+ osteoclasts compared to the control at 21 days (p<0.05). Altogether, these data demonstrate the usefulness of this model to understanding the pathophysiology of MRONJ.


Subject(s)
Aging/metabolism , Bisphosphonate-Associated Osteonecrosis of the Jaw/diagnostic imaging , Tooth Extraction/adverse effects , Zoledronic Acid/adverse effects , Animals , Bisphosphonate-Associated Osteonecrosis of the Jaw/metabolism , Calcification, Physiologic , Collagen/metabolism , Core Binding Factor Alpha 1 Subunit/metabolism , Disease Models, Animal , Female , Mice , Transforming Growth Factor beta/metabolism , X-Ray Microtomography/methods
3.
Braz. oral res. (Online) ; 33: e050, 2019. tab, graf
Article in English | LILACS | ID: biblio-1011654

ABSTRACT

Abstract The present study aimed to investigate the use of platelet-rich plasma (PRP) on tooth extraction sites in rats treated with bisphosphonates. Thirty Albinus Wistar male rats were administered 0.035 mg/kg zoledronic acid intravenously for 8 weeks, divided into four administrations with a 2-week interval between each application, after which their upper right central incisors were extracted to induce the development of bisphosphonate-related osteonecrosis of the jaw (BRONJ). The samples were divided into the following two groups: Group 1 (G1) underwent marginal resection of BRONJ followed by the use of PRP, while Group 2 (G2) underwent resection of BRONJ but without the use of PRP. The treatment groups were evaluated after 14, 28, and 42 days. Clinical, microtomographic, microscopic, and immunohistochemical (IHC) evaluations were performed. Microtomography results revealed no significant difference between the groups (p <0.05) in any time period. Histomorphometric analysis showed increased bone formation over time for both groups (p < 0.001). G1 demonstrated a greater amount of new bone formation than G2 at 28 and 42 days (p < 0.001), with G1 presenting greater vascularization and a slightly higher VEGF expression. For both groups, RANKL/OPG expression levels were sufficient as a parameter for indicating the rate of bone remodeling in a previously treated area of osteonecrosis groups. Taken together, our findings indicated that the use of PRP improves the resolution process of BRONJ.


Subject(s)
Animals , Male , Rats , Diphosphonates/therapeutic use , Bone Density Conservation Agents/therapeutic use , Platelet-Rich Plasma , Bisphosphonate-Associated Osteonecrosis of the Jaw/therapy , Osteoclasts/drug effects , Tooth Extraction/adverse effects , Wound Healing , Rats, Wistar , Disease Models, Animal , Bisphosphonate-Associated Osteonecrosis of the Jaw/physiopathology , Bisphosphonate-Associated Osteonecrosis of the Jaw/pathology
4.
Toxicology ; 409: 1-12, 2018 11 01.
Article in English | MEDLINE | ID: mdl-29990519

ABSTRACT

Manganese (Mn) is one of the most common chemical elements on Earth and an essential micronutrient in animal organism. However, in supraphysiological levels and long-term exposures, it is a potential toxicant. Although nervous system is the most studied in relation to Mn toxicity, other tissues can have their function impaired by Mn in high doses. The present study investigated the possible adverse effects of subchronic exposure to supraphysiologic level of Mn (5 mg/kg or 15 mg/kg, intraperitoneally) on reproductive, neurobehavioral, renal and hepatic parameters of male rats. For the first time, the vulnerability of these parameters to Mn was concomitantly investigated. While our results demonstrate that Mn treatments were not sufficient to produce a marked effect of neurotoxic, hepatotoxic or renal toxicity in adult rats, we found typical indicators of reproductive toxicity such as histopathological changes (major in testes and epididymis) and impaired sperm concentration and quality. Mn, under these experimental conditions, seems to exert reproductive toxicity by different testicular mechanisms, i.e. direct and indirect action on germ cells. On the other hand, exposure to Mn did not change the pattern of cognitive and emotional behaviors and the histological organization of kidneys of experimental rats. The liver showed a weight increasement and hidropic degeneration, probable due to the detoxification overload. In summary, for the first time it was demonstrated that adult male reproductive system was more sensitive to Mn toxicity than nervous, hepatic and renal systems, although nervous system is known as the main target tissue of this metal.


Subject(s)
Manganese/toxicity , Animals , Behavior, Animal/drug effects , Epididymis/drug effects , Epididymis/pathology , Kidney/anatomy & histology , Kidney/drug effects , Liver/drug effects , Liver/pathology , Locomotion/drug effects , Male , Maze Learning/drug effects , Rats, Wistar , Spermatozoa/drug effects , Testis/drug effects , Testis/pathology , Toxicity Tests, Subchronic
5.
Ann Hum Genet ; 82(3): 135-142, 2018 05.
Article in English | MEDLINE | ID: mdl-29250766

ABSTRACT

miRNAs appear to play an important role in controlling the expression of several genes, and they are a potential biomarker and prognostic tool in gastric diseases. We analyzed 53 controls, 86 patients with gastritis, and 19 patients with gastric cancer. Real-time-PCR was used to determine the expression levels of miRNA-146a, miRNA-155, IL-2, and TNF-α. The subsequent analysis of the target genes was performed using the bioinformatics approach. There was no difference in IL-2 expression between the groups. However, there was a significant increase in TNF-α expression in the gastritis group relative to the control and a significant decrease in the gastric cancer group relative to the control. There was also a statistically significant increase in miRNA-146a and miRNA-155 expression in the gastritis group relative to the control, but not in the gastric cancer group. Similar results were found when the presence of H. pylori was considered. The data revealed an increase in miRNA-146a and miRNA-155 expression but not enough to control the expression of TNF-α. The presence of H. pylori was found to affect increases in TNF-α and microRNA expression, and miRNA-146a and miRNA-155 alone were not able to eliminate bacteria or restore tissue homeostasis.


Subject(s)
Helicobacter Infections/genetics , Interleukin-2/genetics , MicroRNAs/genetics , Stomach Neoplasms/genetics , Tumor Necrosis Factor-alpha/genetics , Adult , Aged , Case-Control Studies , Female , Gastritis/genetics , Helicobacter Infections/complications , Humans , Inflammation/genetics , Male , Middle Aged , Stomach Neoplasms/microbiology
6.
Int J Exp Pathol ; 97(5): 360-368, 2016 10.
Article in English | MEDLINE | ID: mdl-27917541

ABSTRACT

This study investigated whether or not prepubertal exposure to the fish contaminants methylmercury (MeHg) and the polychlorinated bisphenol Aroclor in low doses interferes with the histomorphometry of the testes, epididymis, liver and kidneys in rats. Wistar male rats, 21 days old, were allocated into the following: control (n = 17, received corn oil), MeHg (n = 17, received MeHg at 0.5 mg/kg/day), Aroclor (n = 17, received Aroclor at 1.0 mg/kg/day), low mix (n = 18, received MeHg at 0.05 mg/kg/day and Aroclor at 0.1 mg/kg/day), high mix (n = 18, received MeHg at 0.5 mg/kg/day and Aroclor at 1.0 mg/kg/day). Dosing continued from post natal day (PND) 23 to 53, by gavage. Euthanasia was performed on PND 53; or, after an interval of 62 days without exposure to chemicals, on PND 115. The degree of maturation of the seminiferous epithelium was delayed in chemical-exposed groups and testicular interstitial oedema was observed at adulthood. The pattern of male gonad organization was changed in the Aroclor group on PND 53 and in all treated groups at adulthood. The animals from Aroclor, low mix and high mix groups showed a reduction in the number of Sertoli cells. Histological evidence of renal injury was observed in all chemical-exposed groups in both ages. A probable target for MeHg and Aroclor in the reproductive system was Sertoli cells, in which possible dysfunctions could be linked to the other testicular alterations. Curiously, the main deleterious effects were late outcomes, along with the absence of synergistic interaction of MeHg and Aroclor in the parameters investigated. In conclusion, fish pollutants MeHg and Aroclor caused permanent structural damage in male gonads and kidneys after prepubertal exposure, without showing clear chemical interactions.


Subject(s)
Aroclors/toxicity , Fishes/metabolism , Food Contamination , Kidney/drug effects , Methylmercury Compounds/toxicity , Testis/drug effects , Animals , Biometry/methods , Environmental Pollutants/toxicity , Female , Kidney/pathology , Liver/drug effects , Liver/pathology , Male , Puberty , Rats, Wistar , Seminiferous Tubules/drug effects , Seminiferous Tubules/pathology , Spermatogenesis/drug effects , Testis/pathology , Weight Gain/drug effects
7.
Rev. Salusvita (Online) ; 34(1)2015. graf, ilus, tab
Article in Portuguese | LILACS | ID: lil-758314

ABSTRACT

Introdução: Neoplasias são células com proliferação e diferenciação anormais. Quando essas células tornam-se capazes de originar outras células em tecidos e vasos diferentes do inicial são denominadas metástases. A melatonina (N-acetil-5-metoxitripamina) é um hormônio secretado pela glândula pineal e que tem associação com o controle celular tumoral. Objetivo: pretendeu-se avaliar o efeito do tratamento com melatonina sobre a produção e crescimento de metástase linfática do tumor sólido de Ehrlich (TE) em camundongos. Método: foram empregados 14 camundongos distribuídos em 2 grupos: controle (GC, N = 07 / 0,1ml de solução fisiológica, via oral, 1x/dia) e teste (GT, N = 07 / 10mg/kg de melatonina, via oral, 1x/ dia). Todos os animais foram inoculados com 10 6 células tumorais no coxim plantar da pata traseira direita. Resultados e Discussão: D=decorridos 17 dias de tratamento os animais foram eutanasiados, removemos as 02 patas traseiras para avaliar o peso da massa tumoral sendo que o grupo controle apresentou peso maior (GC = 0,62 ± 0,14). Também foi removido o linfonodo poplíteo para mensuração da área, constatando redução significativa no grupo teste (GT = 4,37 ± 1,58). A redução da área do linfonodo pode ser associada a uma redução no número de células tumorais presentes nos linfonodos (GT = 62,8 ± 13,07). Conclusão: Concluímos que o tratamento com melatonina reduziu significativamente o crescimento tumoral e metastático do TE.


Introduction: Neoplasms are cells with unusual proliferation and differentiation. When these cells become able to generate other cells in material and veins different from the beginning one arenamed metastasis. The melatonin (N-acetil-5-methoxytryptamine) is a hormone secreted by the pineal gland and it has association with the tumor cell control. Objective: the general aim was to evaluate the treatment result with melatonin on the metastasis lymphatic production and growth of the Ehrlich Tumor in mice. For this experience, 14 mice were used and shared in 2 groups: control (GC, N = 07 / 0,1ml of sterilizing solution, oral, once a day) and test (GT, N = 07 / 10mg/kg of melatonin, oral, once a day). All the animals were inoculated with 106 tumor cells in the footpad of the right back paw. Results and discussion: after 17 days of treatment the animals were euthanized and 2 back paws were removed to evaluate the tumor bulk weight considering that the control group was heavier (GC = 0,62 ± 0,14). The popliteallymph node was also removed for the area measurement where asmaller area for the test group was observed (GT = 62,8 ± 13,07). Conclusion: we concluded that the treatment with melatonin meaningfully reduced the metastatic growth.


Subject(s)
Mice , Carcinoma, Ehrlich Tumor/diagnosis , Carcinoma, Ehrlich Tumor/pathology , Carcinoma, Ehrlich Tumor/therapy , Lymph Nodes/pathology , Melatonin/therapeutic use , Neoplasm Metastasis/therapy
8.
Rev. Salusvita (Online) ; 31(3)2012. tab
Article in Portuguese | LILACS | ID: lil-698398

ABSTRACT

Introdução: Os bambus pertencem à família Graminae, subfamília Bambusoidae, representados por cerca de 1250 espécies no mundo. Originalmente empregados na construção civil e alimentação, atualmente são alvo de investigações relacionadas às suas propriedades terapêuticas em neoplasias. As principais espécies utilizadas para fins terapêuticos baseado no conhecimento popular são: Phyllostachys nigra; Bambusa breiflora; Bambusa tuldoides e a Bambusa textilis. A literatura sobre a ação terapêutica das espécies de bambu é escassa, porém estudos recentes relatam um promissor efeito no tratamento de neoplasias e outras doenças crônicas. Objetivo: O presente estudo teve como principal objetivo avaliar, qualitativamente a composição fitoquímica de extrato vegetal obtido a partir das folhas da espécie de bambu Bambusa textilis, comparando esta composição entre folhas de vegetais com 18 e 24 meses de idade. Metodologia: Após a coleta de folhas do vegetal com 18 ou 24 meses, as mesmas foram identificadas e submetidas à secagem e moagem. Para análise qualitativa de seus componentes foram empregados os métodos de avaliação macroscópica (mucilagens), método do Benjoim (resinas), reação de Shinoda (flavonóides), reação com solução de gelatina (taninos), fervura e formação de espuma (saponinas) e empregos dos reativos de Wagner, Bertrand, Dragendorff, Mayer, ácido pícrico e ácido tânico (alcalóides) (BIAVATTI; LEITE, 2007). Resultados: nas folhas mais jovens foram encontrados resultados positivos para alcalóides, flavonóides, resinas e saponinas. Nas folhas do vegetal com 24 meses foram encontrados apenas alcalóides flavonóides e resinas.


Introduction: Bamboos belong to the family Graminae, Bambusoidae subfamily, represented by about 1,250 species worldwide. Originally employed in construction and power, are currently the subject of investigations related to its therapeutic properties in neoplasms.The main species used for therapeutic purposes based on popular knowledge are: Phyllostachys nigra; Bambusa breiflora; tuldoides Bambusa textilis and Bambusa. The literature on the therapeutic action of bamboo species is scarce, but recent studies report a promising effect in the treatment of cancer and other chronic diseases. Objective: This study aimed to evaluate qualitatively the phytochemical composition of plant extract obtained from the leaves of the bamboo species Bambusa textilis, comparing this composition from vegetable leaves with 18 and 24 months of age. Methodology: After collecting plant leaves with 18 or 24 months, they were identified and submitted to drying and milling. For qualitative analysis of its components were employed methods of macroscopic evaluation (mucilage), method of benzoin (resin), reaction Shinoda (flavonoids), reaction with gelatin solution (tannins), boiling and foaming (saponins) and jobs of reactive Wagner, Bertrand, Dragendorff, Mayer, picric acid and tannic acid (alkaloids) (Biavatti; MILK, 2007). Results: in the youngest leaves were found positive for alkaloids, flavonoids, resins and saponins. In the leaves of the plant with 24 months were found only alkaloids flavonoids and resins.


Subject(s)
Alkaloids , Bambusa/cytology , Pharmacognosy , Flavonoids , Neoplasms/therapy
9.
Rev. bras. farmacogn ; 19(3): 660-663, jul.-set. 2009. tab, ilus
Article in Portuguese | LILACS | ID: lil-537906

ABSTRACT

O Ageratum conyzoides, vegetal conhecido popularmente no Brasil é constituído por várias substâncias químicas, dentre elas os flavonóides, aos quais já foi atribuída a atividade antitumoral. Neste estudo foi avaliado o efeito das frações clorofórmica e metanólica do extrato AcOEt das folhas sobre o crescimento do tumor de Ehrlich. Foi constatado que o tratamento com as frações metanólicas, nas doses de 50 mg/kg de peso foi eficaz, inibindo o crescimento tumoral. A porcentagem de inibição para a fração metanólica estabilizada foi de 69,84 por cento e de 68,25 por cento para a fração metanólica não estabilizada. Estudos posteriores se fazem necessários para esclarecer quais os mecanismos envolvidos nesta inibição do crescimento tumoral.


Ageratum conyzoides, a popular vegetal in Brazil, is composed by many chemical compounds, including flavonoids, and antitumoral activity has been attributed to it. In this assay the effect of chloroform and methanol fractions from EtOAc extract of the leaves on the growth of the Ehrlich tumor was evaluated. Under our experimental conditions we have observed that the treatment with methanol fractions, under the dosage of 50 mg/kg was efficient on inhibiting the tumoral growth. There was an inhibition percentage of 69.84 percent to the stabilized methanol fraction and 68.25 percent to the non-stabilized fraction. Further studies are necessary to clarify which mechanisms are involved in the inhibition of the tumoral growth.

10.
Acta Cir Bras ; 24(2): 107-11, 2009.
Article in English | MEDLINE | ID: mdl-19377778

ABSTRACT

PURPOSE: Evaluate polymorphonuclear leukocytes (PMN's) and mononuclear cells (MN's) involvement in the Ehrlich s solid tumor (ET) growth. METHODS: 90 Swiss mice were inoculated with 10(7) tumor cells (sc), distributed in three groups and treated once a day, via intraperitoneal (ip), with 0.1ml of diluent, L-Arginine (20mg/Kg) or L-NAME (20mg/Kg). After 7, 15 and 30 days of treatment, ten animals of each group were euthanized, the tumor mass was removed, processed and fixed for HE. Later, a morphometric analysis of the total area, parenchyma, necrosis, tumor stroma and PMN's leukocytes and MN's cells influx was performed. RESULTS: The L-Arginine treatment increased PMN's influx in the initial stage, whereas L-NAME reduced it. Our data suggests that NO effect on PMN's migration is dose-dependent. On the other hand, the MN s cells influx was reduced by L-NAME treatment at all evaluated periods and at the same periods an increase in tumor growth was observed. CONCLUSION: At initial stages of tumor implantation, both PMN's leukocytes and MN's cells act together to control ET development.


Subject(s)
Arginine/pharmacology , Carcinoma, Ehrlich Tumor/pathology , Enzyme Inhibitors/pharmacology , Leukocytes, Mononuclear/pathology , NG-Nitroarginine Methyl Ester/pharmacology , Neutrophils/drug effects , Animals , Disease Models, Animal , Leukocytes, Mononuclear/physiology , Male , Mice , Neutrophils/physiology , Nitric Oxide Synthase/metabolism
11.
Acta cir. bras ; 24(2): 107-111, Mar.-Apr. 2009. graf
Article in English | LILACS | ID: lil-511323

ABSTRACT

PURPOSE: Evaluate polymorphonuclear leukocytes (PMN's) and mononuclear cells (MN's) involvement in the Ehrlich´s solid tumor (ET) growth. METHODS: 90 Swiss mice were inoculated with 10(7) tumor cells (sc), distributed in three groups and treated once a day, via intraperitoneal (ip), with 0.1ml of diluent, L-Arginine (20mg/Kg) or L-NAME (20mg/Kg). After 7, 15 and 30 days of treatment, ten animals of each group were euthanized, the tumor mass was removed, processed and fixed for HE. Later, a morphometric analysis of the total area, parenchyma, necrosis, tumor stroma and PMN's leukocytes and MN's cells influx was performed. RESULTS: The L-Arginine treatment increased PMN's influx in the initial stage, whereas L-NAME reduced it. Our data suggests that NO effect on PMN's migration is dose-dependent. On the other hand, the MN´s cells influx was reduced by L-NAME treatment at all evaluated periods and at the same periods an increase in tumor growth was observed. CONCLUSION: At initial stages of tumor implantation, both PMN's leukocytes and MN's cells act together to control ET development.


OBJETIVO: Avaliar o envolvimento de leucócitos polimorfonucleares (PMN's) e células mononucleares (MN's) no crescimento do Tumor Sólido de Ehrlich (TE). MÉTODOS: 90 camundongos Suíços foram inoculados com 10(7) células tumorais (sc), distribuídos em três grupos e tratados uma vez ao dia, via intraperitoneal (ip), com 0.1ml de diluente, L-Arginina (20mg/Kg) ou L-NAME (20mg/Kg). Após 7, 15 e 30 dias, dez animais de cada grupo foram eutanasiados, a massa tumoral foi removida, processada e corada pela HE. Posteriormente, foi realizada análise morfométrica das áreas total, parênquima, necrose, estroma e influxo de leucócitos PMN's e células MN's. RESULTADOS: O tratamento com L-Arginina favoreceu o influxo de PMN's em períodos iniciais, enquanto o tratamento com L-NAME o reduziu. Nosso estudo sugere que o efeito do ON sobre a migração de PMN's é dose-dependente. Por outro lado, o influxo de células MN´s foi contido pelo tratamento com L-NAME em todos os períodos avaliados, mesmos períodos em que se observou um aumento no crescimento tumoral. CONCLUSÃO: Em fases iniciais do implante tumoral, ambos, leucócitos PMN's e células MN's, atuam juntos no controle do desenvolvimento do TE.


Subject(s)
Animals , Male , Mice , Arginine/pharmacology , Carcinoma, Ehrlich Tumor/pathology , Enzyme Inhibitors/pharmacology , Leukocytes, Mononuclear/pathology , NG-Nitroarginine Methyl Ester/pharmacology , Neutrophils/drug effects , Disease Models, Animal , Leukocytes, Mononuclear/physiology , Neutrophils/physiology , Nitric Oxide Synthase/metabolism
12.
Botuactu; s.n; 2005. 60 p. ilus, graf.
Thesis in Portuguese | LILACS | ID: lil-511149

ABSTRACT

Ampla literatura demonstra a participação de cicloxigenases (COXs: COX-1 e/ou COX-2) na evolução de várias neoplasias humanas e experimentais. Este estudo teve por objetivo comparar o efeito de um inibidor não seletivo de COX e um específico de COX-2 na evolução do tumor sólido de Ehrlich (TE). Para tanto, camundongos foram inoculados subcutâneamente com 1 x10 7 células de TE e tratados com indometacina (inibidor de COX-1 e COX-2) ou parecoxibe (inibidor de COX-2), ambos na concentração de 1 mg/kg de peso, 1x/dia, ip, ou com diluente (0,1 ml, 1x/dia, ip). Decorridos sete e quinze dias, os animais foram sacrificados e a massa tumoral avaliada quanto: peso; dimensões da área total, de necrose, de parênquima e estroma tumorais; quantificação de células mononucleares, polimorfonucleares, linfócitos CD3mais, linfócitos CD4mais e linfócitos CD8 mais. O tratamento com indometacina reduziu o peso do TE, a área total e a área do parênquima tumoral, apenas após quinze dias de tratamento e promoveu aumento no influxo de linfócitos CD3mais e CD8mais em todos os períodos avaliados. O tratamento com parecoxibe também reduziu o peso tumoral, porém promoveu um acréscimo na área total do TE, no parênquima e no influxo de linfócitos CD3mais e CD8mais, aos quinze dias de tratamento. Esses resultados sugerem que a COX-1 está mais envolvida no escape do crescimento do TE, ou que COX-1 e COX-2 atuam em fases distintas da evolução do TE.


Subject(s)
Animals , Male , Mice , Carcinoma, Ehrlich Tumor/chemically induced , Indomethacin/agonists , Neoplasms/drug therapy
13.
Rev. Salusvita (Impr.) ; 24(3): 393-410, 2005. tab
Article in Portuguese | LILACS | ID: lil-475965

ABSTRACT

Estudos epidemiológicos revelam que o consumo regular de soja reduz ou suprime o câncer de mama, sendo esse fato associado à presença de isoflavonas, fitoestrógenos contidos nesses grãos. Atribui-se ao estrogênio a facilitação do crescimento de neoplasias mamárias humanas e, por conseqüência, o uso do fitoestrogênio vem se mostrando uma terapia alternativa ao uso de estrogênio. Neste estudo, avaliou-se a ação das isoflavonas sobre o crescimento do tumor de Ehrlich, baseando-se nas determinações de peso, área e proliferação celular. Para tanto, administrou-se uma suspensão de isoflavona, via intraperitoneal, na dose de 20 mg/kg de peso, por 20 dias. Constatou-se que o tratamento com isoflavona é capaz de interferir no ciclo de divisão celular, pois o número de figuras de mitose foi significativamente reduzido no grupo tratado. O peso e as dimensões da massa tumoral não apresentaram dife renças significativas entre os grupos, fato que merece investigação futura...


Subject(s)
Humans , Female , Carcinoma, Ehrlich Tumor/drug therapy , Phytoestrogens , Isoflavones
SELECTION OF CITATIONS
SEARCH DETAIL
...